| scholarly article | Q13442814 |
| P50 | author | Cristina Sánchez | Q39078704 |
| Guillermo Velasco | Q40549742 | ||
| P2093 | author name string | Manuel Guzmán | |
| Teresa Gómez del Pulgar | |||
| Amador Haro | |||
| P2860 | cites work | The AMP-activated protein kinase prevents ceramide synthesis de novo and apoptosis in astrocytes | Q24290792 |
| Human and murine serine-palmitoyl-CoA transferase--cloning, expression and characterization of the key enzyme in sphingolipid synthesis | Q28114891 | ||
| Purification of the serine palmitoyltransferase complex responsible for sphingoid base synthesis by using affinity peptide chromatography techniques | Q28139000 | ||
| Serine palmitoyltransferase regulates de novo ceramide generation during etoposide-induced apoptosis | Q28139061 | ||
| SPTLC1 is mutated in hereditary sensory neuropathy, type 1 | Q28204237 | ||
| Mutations in SPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1, cause hereditary sensory neuropathy type I | Q28204289 | ||
| Structure of a cannabinoid receptor and functional expression of the cloned cDNA | Q28240076 | ||
| Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors | Q28292914 | ||
| Molecular characterization of a peripheral receptor for cannabinoids | Q28298338 | ||
| Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation | Q28372120 | ||
| A mammalian homolog of the yeast LCB1 encodes a component of serine palmitoyltransferase, the enzyme catalyzing the first step in sphingolipid synthesis | Q28587825 | ||
| Isolation and structure of a brain constituent that binds to the cannabinoid receptor | Q29547476 | ||
| Cannabinoid receptor ligands: clinical and neuropharmacological considerations, relevant to future drug discovery and development | Q31522100 | ||
| Signalling sphingomyelinases: which, where, how and why? | Q33601457 | ||
| Ceramide in the eukaryotic stress response | Q33826715 | ||
| Physiology and pathophysiology of sphingolipid metabolism and signaling | Q33930354 | ||
| The endocannabinoid system as a target for therapeutic drugs. | Q33934278 | ||
| The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. | Q34066911 | ||
| Apoptosis in the nervous system | Q34068965 | ||
| Ceramide: a new second messenger of cannabinoid action | Q34133972 | ||
| Control of the cell survival/death decision by cannabinoids | Q34195687 | ||
| Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes | Q35923385 | ||
| Inhibition of the p44/42 MAP kinase pathway protects hippocampal neurons in a cell-culture model of seizure activity | Q36327960 | ||
| Ataxia telangiectasia-mutated gene product inhibits DNA damage-induced apoptosis via ceramide synthase | Q38323889 | ||
| Production of ceramides causes apoptosis during early neural differentiation in vitro | Q40872435 | ||
| Ceramide inhibits protein kinase B/Akt by promoting dephosphorylation of serine 473. | Q40883173 | ||
| Delta9-tetrahydrocannabinol induces apoptosis in C6 glioma cells. | Q41002908 | ||
| Inhibition of carnitine palmitoyltransferase I augments sphingolipid synthesis and palmitate-induced apoptosis | Q41128299 | ||
| Medicinal applications of delta-9-tetrahydrocannabinol and marijuana | Q41468383 | ||
| Regulation of ceramide production and apoptosis | Q41748407 | ||
| Involvement of sphingomyelin hydrolysis and the mitogen-activated protein kinase cascade in the Delta9-tetrahydrocannabinol-induced stimulation of glucose metabolism in primary astrocytes. | Q42463589 | ||
| Mammalian cell mutants resistant to a sphingomyelin-directed cytolysin. Genetic and biochemical evidence for complex formation of the LCB1 protein with the LCB2 protein for serine palmitoyltransferase | Q42819525 | ||
| Rap1 mediates sustained MAP kinase activation induced by nerve growth factor | Q42830846 | ||
| The CB(1) cannabinoid receptor of astrocytes is coupled to sphingomyelin hydrolysis through the adaptor protein fan. | Q43578243 | ||
| UVB irradiation up-regulates serine palmitoyltransferase in cultured human keratinocytes. | Q46000073 | ||
| Evidence for the lack of involvement of sphingomyelin hydrolysis in the tumor necrosis factor-induced secretion of nerve growth factor in primary astrocyte cultures. | Q47778008 | ||
| Involvement of de novo ceramide biosynthesis in tumor necrosis factor-alpha/cycloheximide-induced cerebral endothelial cell death | Q47954345 | ||
| Ceramide signaling downstream of the p75 neurotrophin receptor mediates the effects of nerve growth factor on outgrowth of cultured hippocampal neurons | Q48109056 | ||
| Regional selective neuronal degeneration after protein phosphatase inhibition in hippocampal slice cultures: evidence for a MAP kinase-dependent mechanism. | Q48395929 | ||
| Cannabinoid receptors and their endogenous agonists | Q48464429 | ||
| Δ9 -Tetrahydrocannabinol induces apoptosis in human prostate PC-3 cells via a receptor-independent mechanism | Q62398804 | ||
| De novo-synthesized ceramide signals apoptosis in astrocytes via extracellular signal-regulated kinase | Q73127880 | ||
| Serine palmitoyltransferase | Q73186643 | ||
| Anandamide induces apoptosis in human cells via vanilloid receptors. Evidence for a protective role of cannabinoid receptors | Q74061522 | ||
| Activation of the de novo biosynthesis of sphingolipids mediates angiotensin II type 2 receptor-induced apoptosis | Q77841204 | ||
| The CB1 cannabinoid receptor is coupled to the activation of protein kinase B/Akt | Q95716793 | ||
| P433 | issue | Pt 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cannabinoids | Q422936 |
| ceramides | Q424213 | ||
| P304 | page(s) | 183-188 | |
| P577 | publication date | 2002-04-01 | |
| P1433 | published in | Biochemical Journal | Q864221 |
| P1476 | title | De novo-synthesized ceramide is involved in cannabinoid-induced apoptosis | |
| P478 | volume | 363 |
| Q39881733 | Amphiregulin is a factor for resistance of glioma cells to cannabinoid-induced apoptosis. |
| Q26750399 | Anticancer mechanisms of cannabinoids |
| Q34358271 | Antiproliferative effects of cannabinoid agonists on deep infiltrating endometriosis. |
| Q38806270 | Antitumorigenic targets of cannabinoids - current status and implications |
| Q89605000 | Cannabinoid Signaling in Glioma Cells |
| Q34979866 | Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells |
| Q40214988 | Cannabinoid receptor agonist-induced apoptosis of human prostate cancer cells LNCaP proceeds through sustained activation of ERK1/2 leading to G1 cell cycle arrest |
| Q37546194 | Cannabinoid receptor ligands as potential anticancer agents--high hopes for new therapies? |
| Q35100892 | Cannabinoids and cancer: pros and cons of an antitumour strategy |
| Q36977756 | Cannabinoids and gliomas. |
| Q33310983 | Cannabinoids as potential new therapy for the treatment of gliomas |
| Q27694715 | Cannabinoids, endocannabinoids, and cancer |
| Q34542671 | Cannabinoids: potential anticancer agents |
| Q36892931 | Cannabis and endocannabinoid modulators: Therapeutic promises and challenges |
| Q40623956 | Ceramide Is Involved inR(+)-Methanandamide-Induced Cyclooxygenase-2 Expression in Human Neuroglioma Cells |
| Q38021345 | Ceramide function in the brain: when a slight tilt is enough. |
| Q34955724 | Ceramide regulation of apoptosis versus differentiation: a walk on a fine line. Lessons from neurobiology |
| Q40586806 | Ceramide sensitizes astrocytes to oxidative stress: protective role of cannabinoids |
| Q37164208 | Critical appraisal of the potential use of cannabinoids in cancer management |
| Q36498885 | Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors |
| Q44799706 | De novo ceramide accumulation due to inhibition of its conversion to complex sphingolipids in apoptotic photosensitized cells. |
| Q35114241 | Designing anticancer drugs via the achilles heel: ceramide, allylic ketones, and mitochondria |
| Q37405849 | Dihydroceramide accumulation mediates cytotoxic autophagy of cancer cells via autolysosome destabilization |
| Q46427095 | Endocannabinoid metabolism in human glioblastomas and meningiomas compared to human non-tumour brain tissue |
| Q26739831 | Endocannabinoid system as a regulator of tumor cell malignancy - biological pathways and clinical significance |
| Q38593139 | Endocannabinoids and Cancer. |
| Q55467310 | Expression of cannabinoid receptors and neurotrophins in human gliomas. |
| Q40604593 | Gamma-irradiation enhances apoptosis induced by cannabidiol, a non-psychotropic cannabinoid, in cultured HL-60 myeloblastic leukemia cells |
| Q48128574 | Gαs signalling of the CB1 receptor and the influence of receptor number |
| Q37339555 | Hepatic cannabinoid-1 receptors mediate diet-induced insulin resistance by increasing de novo synthesis of long-chain ceramides |
| Q93065228 | Identification of Novel Predictive Biomarkers for Endometrial Malignancies: N-Acylethanolamines |
| Q24321982 | Identification of small subunits of mammalian serine palmitoyltransferase that confer distinct acyl-CoA substrate specificities |
| Q38990460 | In vitro and in vivo efficacy of non-psychoactive cannabidiol in neuroblastoma |
| Q34998169 | Inhibition of human tumour prostate PC-3 cell growth by cannabinoids R(+)-Methanandamide and JWH-015: involvement of CB2 |
| Q24529892 | Killing tumours by ceramide-induced apoptosis: a critique of available drugs |
| Q57364601 | Metabolism and physiological functions of sphingolipids |
| Q33939529 | Mitochondrial ceramide-rich macrodomains functionalize Bax upon irradiation |
| Q38008481 | New trends for the medical treatment of endometriosis |
| Q39902384 | Phosphatidylinositol 3-kinase/AKT pathway regulates the endoplasmic reticulum to golgi traffic of ceramide in glioma cells: a link between lipid signaling pathways involved in the control of cell survival. |
| Q39824459 | Potentiation of cannabinoid-induced cytotoxicity in mantle cell lymphoma through modulation of ceramide metabolism |
| Q38918051 | Proapoptotic effect of endocannabinoids in prostate cancer cells |
| Q46788902 | R(+)-methanandamide elicits a cyclooxygenase-2-dependent mitochondrial apoptosis signaling pathway in human neuroglioma cells |
| Q34202240 | Serine palmitoyltransferase, a key enzyme of sphingolipid metabolism |
| Q38195691 | Sphingolipids: key regulators of apoptosis and pivotal players in cancer drug resistance |
| Q38154188 | Systematic review of the literature on clinical and experimental trials on the antitumor effects of cannabinoids in gliomas |
| Q40290354 | The CB2 cannabinoid receptor signals apoptosis via ceramide-dependent activation of the mitochondrial intrinsic pathway. |
| Q64072053 | The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet? |
| Q36666503 | The cannabinoid receptors are required for ultraviolet-induced inflammation and skin cancer development |
| Q55415383 | The current state and future perspectives of cannabinoids in cancer biology. |
| Q45287768 | The endocannabinoid anandamide induces apoptosis of rat decidual cells through a mechanism involving ceramide synthesis and p38 MAPK activation |
| Q37393042 | The endocannabinoid system and sex steroid hormone-dependent cancers. |
| Q24648473 | The endocannabinoid system as an emerging target of pharmacotherapy |
| Q35204851 | The endocannabinoid system, anandamide and the regulation of mammalian cell apoptosis |
| Q64284375 | The onus of cannabinoids in interrupting the molecular odyssey of breast cancer: A critical perspective on UPR and beyond |
| Q38196323 | The role of monoacylglycerol lipase (MAGL) in the cancer progress |
| Q24642219 | The sphingolipid salvage pathway in ceramide metabolism and signaling |
| Q84066889 | Towards the use of cannabinoids as antitumour agents |
| Q46684067 | p38 MAPK is involved in CB2 receptor-induced apoptosis of human leukaemia cells |
Search more.